fbpx

A Cancer Treatment Causes Side Effect of Night Vision

Research published in the Journal of Physical Chemistry Letters explained why photodynamic cancer therapy causes night vision in patients. Photodynamic therapy is a form of cancer treatment that uses light to destroy malignant cells. The interesting side effect patients have reported is night vision seen as silhouettes and outlines in the dark. Only now have researchers discovered the mechanics of this phenomenon.

The Mechanics of Night Vision

Photodynamic therapy involves injections of chlorin e6, a photosensitive compound. It’s the reaction between chlorin e6 and rhodopsin in the retinal photoreceptors rods that causes the apparent night vision to occur. Normally we see with visible light because of a compound in our eye called retinal being triggered by visible light. After triggering, retinal separates from rhodopsin, a light-sensitive protein in the retinas of our eyes, and an electrical signal is transmitted to our brain to interpret what we see. In the case of night vision seen by these cancer patients, infrared light combined with the chlorin e6 changes retinal in the same way it does under visible light conditions. “This explains the increase in night-time visual acuity,” chemist Antonio Monari, from the University of Lorraine in France tells CNRS (French National Centre for Scientific Research).

Using Molecular Simulation to Understand Chemical Reactions

The researchers used molecular simulation to model the movements of individual atoms as well as the breaking or creating of chemical bonds. It took several months of testing various simulations with millions of calculations before it was able to accurately model the chemical reaction caused by infrared radiation. “For our simulation we placed a virtual rhodopsin protein inserted in its lipid membrane in contact with several chlorin e6 molecules and water, or several tens of thousands of atoms,” Monari told CNRS.

Molecular simulation is a powerful tool and can help us better understand fundamental mechanisms. For example, it can help understand why certain DNA lesions are better repaired than others and help select the best therapeutic molecules by mimicking their interaction in a simulated model.

Reference: https://www.sciencealert.com/scientists-have-figured-out-how-a-cancer-treatment-gives-patients-night-vision

Featured Posts

World Council of Optometry

WCO Announces 2026–2028 Standing Committee Chairs

The World Council of Optometry has announced the acclaimed Chairs of its Standing Committees for the 2026–2028 term: Prof. Vanessa Moodley, Dr. Roger Jordan and Ntombikayise Zitha.

Learn More
Canadian Ophthalmological Society

Vision Health Partners’ Coalition Urges Federal Investment to Establish Canada’s National Eye Care Strategy

The Vision Health Partners’ Coalition is urging Ottawa to fund the implementation of Canada’s National Strategy for Eye Care, including a public awareness campaign and national steering committee.

Read more
DaTE Redefinign Boundaries logo 2025

DaTE 2026 Opens Exhibitor List and Registration for Napoli Edition

DaTE has published the exhibitor list for its 2026 Napoli edition and opened registration for visitors and press ahead of the September event.

Read more
Neutral medical documentation in eye care

The Paper Trail of Frustration

Avoid "emotional leakage" in your EMR. Learn why neutral medical documentation is a professional necessity in the era of open patient portals and how to reframe difficult patient encounters with high EQ.

Read more
Silmo Paris nouvelle image de marque 2026

Joachim Froment Named Jury President for SILMO d’Or 2026

SILMO Paris has appointed Brussels-based designer Joachim Froment as president of the jury for the SILMO d’Or 2026.

Read more
World Council of Optometry

WCO Announces 2026–2028 Standing Committee Chairs

The World Council of Optometry has announced the acclaimed Chairs of its Standing Committees for the 2026–2028 term: Prof. Vanessa Moodley, Dr. Roger Jordan and Ntombikayise Zitha.

Learn More
Canadian Ophthalmological Society

Vision Health Partners’ Coalition Urges Federal Investment to Establish Canada’s National Eye Care Strategy

The Vision Health Partners’ Coalition is urging Ottawa to fund the implementation of Canada’s National Strategy for Eye Care, including a public awareness campaign and national steering committee.

Read More
DaTE Redefinign Boundaries logo 2025

DaTE 2026 Opens Exhibitor List and Registration for Napoli Edition

DaTE has published the exhibitor list for its 2026 Napoli edition and opened registration for visitors and press ahead of the September event.

Read More
Neutral medical documentation in eye care

The Paper Trail of Frustration

Avoid "emotional leakage" in your EMR. Learn why neutral medical documentation is a professional necessity in the era of open patient portals and how to reframe difficult patient encounters with high EQ.

Read More
Silmo Paris nouvelle image de marque 2026

Joachim Froment Named Jury President for SILMO d’Or 2026

SILMO Paris has appointed Brussels-based designer Joachim Froment as president of the jury for the SILMO d’Or 2026.

Read More
World Council of Optometry

WCO Announces 2026–2028 Standing Committee Chairs

The World Council of Optometry has announced the acclaimed Chairs of its Standing Committees for the 2026–2028 term: Prof. Vanessa Moodley, Dr. Roger Jordan and Ntombikayise Zitha.

Learn More
Canadian Ophthalmological Society

Vision Health Partners’ Coalition Urges Federal Investment to Establish Canada’s National Eye Care Strategy

The Vision Health Partners’ Coalition is urging Ottawa to fund the implementation of Canada’s National Strategy for Eye Care, including a public awareness campaign and national steering committee.

Read more
DaTE Redefinign Boundaries logo 2025

DaTE 2026 Opens Exhibitor List and Registration for Napoli Edition

DaTE has published the exhibitor list for its 2026 Napoli edition and opened registration for visitors and press ahead of the September event.

Read more
Neutral medical documentation in eye care

The Paper Trail of Frustration

Avoid "emotional leakage" in your EMR. Learn why neutral medical documentation is a professional necessity in the era of open patient portals and how to reframe difficult patient encounters with high EQ.

Read more
Silmo Paris nouvelle image de marque 2026

Joachim Froment Named Jury President for SILMO d’Or 2026

SILMO Paris has appointed Brussels-based designer Joachim Froment as president of the jury for the SILMO d’Or 2026.

Read more
World Council of Optometry

WCO Announces 2026–2028 Standing Committee Chairs

The World Council of Optometry has announced the acclaimed Chairs of its Standing Committees for the 2026–2028 term: Prof. Vanessa Moodley, Dr. Roger Jordan and Ntombikayise Zitha.

Learn More
Canadian Ophthalmological Society

Vision Health Partners’ Coalition Urges Federal Investment to Establish Canada’s National Eye Care Strategy

The Vision Health Partners’ Coalition is urging Ottawa to fund the implementation of Canada’s National Strategy for Eye Care, including a public awareness campaign and national steering committee.

Read more
DaTE Redefinign Boundaries logo 2025

DaTE 2026 Opens Exhibitor List and Registration for Napoli Edition

DaTE has published the exhibitor list for its 2026 Napoli edition and opened registration for visitors and press ahead of the September event.

Read more
Neutral medical documentation in eye care

The Paper Trail of Frustration

Avoid "emotional leakage" in your EMR. Learn why neutral medical documentation is a professional necessity in the era of open patient portals and how to reframe difficult patient encounters with high EQ.

Read more
Silmo Paris nouvelle image de marque 2026

Joachim Froment Named Jury President for SILMO d’Or 2026

SILMO Paris has appointed Brussels-based designer Joachim Froment as president of the jury for the SILMO d’Or 2026.

Read more